share_log

HC Wainwright & Co. Maintains Buy on Pacira BioSciences, Lowers Price Target to $57

HC Wainwright & Co. Maintains Buy on Pacira BioSciences, Lowers Price Target to $57

HC Wainwright & Co.维持对Pacira BioSciences的买入,将目标股价下调至57美元
Benzinga ·  2023/11/06 06:32

HC Wainwright & Co. analyst Oren Livnat maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and lowers the price target from $63 to $57.

HC Wainwright & Co. 分析师奥伦·利夫纳特维持Pacira BioSciences(纳斯达克股票代码:PCRX)的买入,并将目标股价从63美元下调至57美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发